Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for GDRX

Stock NameGoodrx Holdings Inc
TickerGDRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS38246G1085

Show aggregate GDRX holdings

News associated with GDRX

GoodRx, Novo Nordisk Partner To Offer Ozempic And Wegovy For $499 Per Month
(RTTNews) - GoodRx Holdings, Inc. (GDRX), a platform for medication savings in the U.S., Monday said it has partnered with Novo Nordisk to offer diabetes medicine Ozempic and obesity treatment Wegovy for $499 per month to self-paying customers. - 2025-08-18 10:47:23
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Purchased by Headlands Technologies LLC
Headlands Technologies LLC boosted its holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 213.2% in the 1st quarter, HoldingsChannel.com reports. The firm owned 14,830 shares of the company’s stock after buying an additional 10,095 shares during the quarter. Headlands Technologies LLC’s holdings in GoodRx were worth $65,000 at the end of the most […] - 2025-08-13 05:24:58
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Bought by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. raised its holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 12.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 362,713 shares of the company’s stock after acquiring an additional 39,337 shares during the quarter. Assenagon Asset Management S.A.’s holdings in GoodRx were worth $1,600,000 as of its […] - 2025-06-18 04:42:57
Deutsche Bank AG Purchases New Position in GoodRx Holdings, Inc. (NASDAQ:GDRX)
Deutsche Bank AG acquired a new position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 29,380 shares of the company’s stock, valued at approximately $137,000. Several other large investors also recently bought and sold shares of GDRX. […] - 2025-06-04 04:34:57
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Position Reduced by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lessened its position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 17.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 43,300 shares of the company’s stock after selling 9,250 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in GoodRx were worth […] - 2025-06-02 04:54:48
Two Sigma Investments LP Buys 357,674 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)
Two Sigma Investments LP grew its stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 98.1% in the 4th quarter, Holdings Channel.com reports. The fund owned 722,374 shares of the company’s stock after acquiring an additional 357,674 shares during the period. Two Sigma Investments LP’s holdings in GoodRx were worth $3,359,000 as […] - 2025-05-30 05:40:58
Northern Trust Corp Has $1.96 Million Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)
Northern Trust Corp lifted its stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 13.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 421,810 shares of the company’s stock after acquiring an additional 50,256 shares during the period. Northern Trust Corp’s holdings in GoodRx were worth $1,961,000 as of its most […] - 2025-05-27 05:18:55
Lazard Asset Management LLC Sells 51,337 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX)
Lazard Asset Management LLC decreased its holdings in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 90.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,656 shares of the company’s stock after selling 51,337 shares during the period. Lazard Asset Management LLC’s holdings […] - 2025-05-27 04:42:52
Analysts Set GoodRx Holdings, Inc. (NASDAQ:GDRX) Target Price at $6.55
Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy […] - 2025-05-26 04:46:59
GoodRx (NASDAQ:GDRX) and Computer Services (OTCMKTS:CSVI) Head-To-Head Contrast
GoodRx (NASDAQ:GDRX – Get Free Report) and Computer Services (OTCMKTS:CSVI – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Institutional & Insider Ownership 63.8% of GoodRx shares are […] - 2025-05-23 02:32:57
Envestnet Asset Management Inc. Invests $84,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)
Envestnet Asset Management Inc. acquired a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 18,034 shares of the company’s stock, valued at approximately $84,000. A number of other institutional investors also recently bought and sold shares of GDRX. National Bank […] - 2025-05-09 04:54:57
Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price
GoodRx (NASDAQ:GDRX – Free Report) had its target price reduced by Wells Fargo & Company from $8.00 to $7.00 in a report published on Tuesday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other research analysts have also commented on the company. KeyCorp cut their price target on GoodRx […] - 2025-05-02 04:32:51
Analysts Set GoodRx Holdings, Inc. (NASDAQ:GDRX) Target Price at $7.93
Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has issued a strong buy […] - 2025-04-29 03:10:56
ExodusPoint Capital Management LP Invests $322,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)
ExodusPoint Capital Management LP bought a new position in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 69,277 shares of the company’s stock, valued at approximately $322,000. Several other hedge funds have also modified their […] - 2025-04-14 05:05:17
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC reduced its stake in GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 30.3% during the 4th quarter, Holdings Channel reports. The institutional investor owned 25,216 shares of the company’s stock after selling 10,972 shares during the period. Commonwealth Equity Services LLC’s holdings in GoodRx were worth $117,000 at the end of […] - 2025-04-11 04:32:52
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by Thrivent Financial for Lutherans
Thrivent Financial for Lutherans lowered its position in GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) by 28.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 88,943 shares of the company’s stock after selling 35,906 shares during the quarter. Thrivent Financial for Lutherans’ holdings in GoodRx were worth $413,000 at the end of the most […] - 2025-04-04 04:34:56
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.18 Consensus PT from Analysts
Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) have been given an average rating of “Moderate Buy” by the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy […] - 2025-04-04 03:05:03
EntryPoint Capital LLC Acquires New Holdings in GoodRx Holdings, Inc. (NASDAQ:GDRX)
EntryPoint Capital LLC bought a new position in GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 12,094 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds and other institutional investors also recently made changes to their positions in GDRX. Charles Schwab […] - 2025-03-31 05:32:51
GoodRx (NASDAQ:GDRX) & Paranovus Entertainment Technology (NASDAQ:PAVS) Head-To-Head Review
GoodRx (NASDAQ:GDRX – Get Free Report) and Paranovus Entertainment Technology (NASDAQ:PAVS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Insider and Institutional Ownership 63.8% of GoodRx […] - 2025-03-25 04:10:48
Aigen Investment Management LP Acquires Shares of 13,332 GoodRx Holdings, Inc. (NASDAQ:GDRX)
Aigen Investment Management LP acquired a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 13,332 shares of the company’s stock, valued at approximately $62,000. Several other large investors have also bought and sold shares of the company. M&T Bank Corp bought a […] - 2025-03-11 06:28:53
Brokerages Set GoodRx Holdings, Inc. (NASDAQ:GDRX) PT at $8.18
GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the […] - 2025-03-10 03:53:04
GoodRx Target of Unusually High Options Trading (NASDAQ:GDRX)
GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) saw some unusual options trading activity on Monday. Stock investors bought 8,411 call options on the stock. This represents an increase of 1,884% compared to the typical daily volume of 424 call options. Wall Street Analysts Forecast Growth Several analysts have issued reports on GDRX shares. Morgan […] - 2025-02-26 04:20:57
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives $8.38 Consensus Target Price from Brokerages
GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation, nine have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-02-13 06:26:59

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc GDRX holdings

DateNumber of GDRX Shares HeldBase Market Value of GDRX SharesLocal Market Value of GDRX SharesChange in GDRX Shares HeldChange in GDRX Base ValueCurrent Price per GDRX Share HeldPrevious Price per GDRX Share Held
2025-11-13 (Thursday)12,206USD 37,472USD 37,472
2025-11-12 (Wednesday)12,206GDRX holding decreased by -40USD 37,350GDRX holding increased by 245USD 37,350-40USD 245 USD 3.05997 USD 3.02997
2025-11-11 (Tuesday)12,246USD 37,105GDRX holding decreased by -368USD 37,1050USD -368 USD 3.02997 USD 3.06002
2025-11-10 (Monday)12,246USD 37,473GDRX holding decreased by -612USD 37,4730USD -612 USD 3.06002 USD 3.11
2025-11-07 (Friday)12,246USD 38,085GDRX holding decreased by -612USD 38,0850USD -612 USD 3.11 USD 3.15997
2025-11-06 (Thursday)12,246GDRX holding decreased by -40USD 38,697GDRX holding decreased by -2215USD 38,697-40USD -2,215 USD 3.15997 USD 3.32997
2025-11-05 (Wednesday)12,286GDRX holding decreased by -400USD 40,912GDRX holding decreased by -444USD 40,912-400USD -444 USD 3.32997 USD 3.25997
2025-11-04 (Tuesday)12,686GDRX holding decreased by -80USD 41,356GDRX holding decreased by -899USD 41,356-80USD -899 USD 3.25997 USD 3.30996
2025-11-03 (Monday)12,766GDRX holding decreased by -80USD 42,255GDRX holding decreased by -1036USD 42,255-80USD -1,036 USD 3.30996 USD 3.37
2025-10-31 (Friday)12,846USD 43,291GDRX holding decreased by -899USD 43,2910USD -899 USD 3.37 USD 3.43998
2025-10-30 (Thursday)12,846USD 44,190GDRX holding decreased by -1028USD 44,1900USD -1,028 USD 3.43998 USD 3.52001
2025-10-29 (Wednesday)12,846USD 45,218GDRX holding decreased by -1798USD 45,2180USD -1,798 USD 3.52001 USD 3.65997
2025-10-28 (Tuesday)12,846GDRX holding increased by 120USD 47,016GDRX holding decreased by -961USD 47,016120USD -961 USD 3.65997 USD 3.77
2025-10-27 (Monday)12,726USD 47,977GDRX holding decreased by -2291USD 47,9770USD -2,291 USD 3.77 USD 3.95002
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of GDRX by Blackrock for IE00B3VWM098

Show aggregate share trades of GDRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-403.1203.025 3.035USD -121 4.59 Profit of 62 on sale
2025-11-06SELL-403.3503.000 3.035USD -121 4.62 Profit of 63 on sale
2025-11-05SELL-4003.4903.250 3.274USD -1,310 4.63 Profit of 542 on sale
2025-11-04SELL-803.3303.210 3.222USD -258 4.64 Profit of 113 on sale
2025-11-03SELL-803.3853.250 3.263USD -261 4.64 Profit of 110 on sale
2025-10-28BUY1203.6603.810 3.795USD 455 4.67
2025-10-24SELL-403.9504.050 4.040USD -162 4.68 Profit of 25 on sale
2025-10-15BUY2404.0204.300 4.272USD 1,025 4.71
2025-10-02BUY404.4955.020 4.967USD 199 4.71
2025-09-30BUY804.2304.350 4.338USD 347 4.71
2025-08-21SELL-404.4904.630 4.616USD -185 4.73 Profit of 4 on sale
2025-07-31BUY1204.7904.890 4.880USD 586 4.73
2025-06-30SELL-804.9805.065 5.057USD -405 4.71 Loss of -28 on sale
2025-06-25SELL-404.9105.105 5.086USD -203 4.71 Loss of -15 on sale
2025-06-20SELL-804.6004.660 4.654USD -372 4.71 Profit of 4 on sale
2025-05-23BUY403.7403.780 3.776USD 151 4.80
2025-05-19SELL-403.9503.975 3.972USD -159 4.83 Profit of 34 on sale
2025-05-15SELL-1204.0104.300 4.271USD -513 4.85 Profit of 69 on sale
2025-05-12SELL-404.3504.610 4.584USD -183 4.86 Profit of 11 on sale
2025-05-09SELL-404.3204.465 4.451USD -178 4.87 Profit of 17 on sale
2025-04-30SELL-404.6304.655 4.653USD -186 4.90 Profit of 10 on sale
2025-04-24SELL-804.8004.840 4.836USD -387 4.90 Profit of 5 on sale
2025-04-17SELL-404.4854.490 4.489USD -180 4.93 Profit of 17 on sale
2025-04-15SELL-1204.4904.605 4.593USD -551 4.94 Profit of 41 on sale
2025-04-14SELL-1204.4904.560 4.553USD -546 4.94 Profit of 47 on sale
2025-04-09SELL-1604.6904.735 4.731USD -757 4.96 Profit of 36 on sale
2025-04-07SELL-2804.0104.215 4.195USD -1,174 4.98 Profit of 219 on sale
2025-04-04SELL-4004.1204.230 4.219USD -1,688 4.99 Profit of 308 on sale
2025-03-31BUY404.4104.500 4.491USD 180 5.01
2025-03-19SELL-804.7904.860 4.853USD -388 5.05 Profit of 16 on sale
2025-03-14SELL-2404.4204.585 4.569USD -1,096 5.07 Profit of 121 on sale
2025-03-13SELL-804.4704.630 4.614USD -369 5.08 Profit of 37 on sale
2025-03-12SELL-1,3604.6604.770 4.759USD -6,472 5.09 Profit of 447 on sale
2025-03-07SELL-804.6104.740 4.727USD -378 5.11 Profit of 31 on sale
2025-03-06SELL-1204.6404.925 4.897USD -588 5.12 Profit of 27 on sale
2025-03-03SELL-404.8505.205 5.169USD -207 5.13 Loss of -1 on sale
2025-02-28SELL-2404.9805.010 5.007USD -1,202 5.14 Profit of 31 on sale
2025-02-26SELL-404.8905.090 5.070USD -203 5.14 Profit of 3 on sale
2025-02-25SELL-1204.6504.930 4.902USD -588 5.15 Profit of 30 on sale
2025-02-18BUY2005.0805.220 5.206USD 1,041 5.17
2025-02-13BUY405.0305.040 5.039USD 202 5.18
2025-02-12BUY404.8304.930 4.920USD 197 5.19
2025-02-11BUY1204.8905.080 5.061USD 607 5.19
2025-02-06BUY3604.8204.900 4.892USD 1,761 5.21
2025-01-27BUY404.8504.980 4.967USD 199 5.30
2024-12-30BUY2004.5104.670 4.654USD 931 5.36
2024-12-06BUY1604.9105.026 5.014USD 802 5.41
2024-12-05BUY404.9005.080 5.062USD 202 5.43
2024-12-04BUY2005.0705.090 5.088USD 1,018 5.44
2024-11-29BUY2004.8404.920 4.912USD 982 5.50
2024-11-27BUY1604.8604.885 4.883USD 781 5.56
2024-11-26BUY404.7604.870 4.859USD 194 5.59
2024-11-21BUY2004.2904.395 4.384USD 877 5.74
2024-11-20BUY1204.3104.315 4.315USD 518 5.82
2024-11-18BUY4804.2704.390 4.378USD 2,101 6.01
2024-11-12BUY3204.7004.950 4.925USD 1,576 6.10
2024-11-08BUY2004.8905.120 5.097USD 1,019 6.19
2024-11-07BUY6005.0406.010 5.913USD 3,548 6.27
2024-11-06BUY806.1106.280 6.263USD 501 6.29
2024-10-31BUY406.1206.420 6.390USD 256 6.42
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of GDRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19893,0115,2101,826,42448.9%
2025-09-18770,0318,6491,471,82352.3%
2025-09-17437,5180997,26143.9%
2025-09-16535,2245,6611,038,89251.5%
2025-09-15504,69311,047,97048.2%
2025-09-12286,5063,112679,28342.2%
2025-09-11394,70929,879713,33755.3%
2025-09-10402,00525,124661,94360.7%
2025-09-09318,169700616,67851.6%
2025-09-08787,612141,2661,561,04350.5%
2025-09-051,422,012465,6142,493,51657.0%
2025-09-04427,3511881,162,47136.8%
2025-09-03209,869400401,78252.2%
2025-09-02294,1060702,10341.9%
2025-08-29347,8960702,06949.6%
2025-08-28334,4155,192693,71448.2%
2025-08-27455,20301,021,23744.6%
2025-08-26504,67601,369,55336.8%
2025-08-251,027,36011,4802,472,21341.6%
2025-08-22727,1974982,114,02534.4%
2025-08-211,300,99602,843,88345.7%
2025-08-201,324,1547003,686,20035.9%
2025-08-192,579,8514,7076,902,28137.4%
2025-08-1813,197,45266,66231,557,89741.8%
2025-08-15161,247844853,79018.9%
2025-08-14419,5205001,506,56227.8%
2025-08-13223,9689,957616,53436.3%
2025-08-12288,596600651,56744.3%
2025-08-11455,6814831,41754.8%
2025-08-08804,529135,4851,650,35148.7%
2025-08-072,838,798581,3134,263,84166.6%
2025-08-06415,94341,156705,39759.0%
2025-08-05334,17116,743661,60150.5%
2025-08-04141,3100345,61040.9%
2025-08-01170,8450354,40648.2%
2025-07-31125,080195216,97757.6%
2025-07-30152,3890328,18846.4%
2025-07-29163,581250287,56856.9%
2025-07-2896,2110246,36539.1%
2025-07-2590,8930212,62342.7%
2025-07-24132,0560305,31243.3%
2025-07-23145,198608437,99533.2%
2025-07-22177,4480483,60836.7%
2025-07-21138,965186409,91033.9%
2025-07-18157,591700432,15536.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.